Prevalence and outcomes of anemia in cancer: a systematic review of the literature
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (7), 11-26
- https://doi.org/10.1016/j.amjmed.2003.12.008
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Erythropoietin Treatment in Metastatic Breast CancerActa Oncologica, 2002
- Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective surveyEuropean Journal Of Cancer, 2001
- Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyCancer, 1995
- Implications of the Anemia of Chronic Disorders in Patients Anticipating RadiotherapyThe Lancet Healthy Longevity, 1994
- Erythropoietin for anaemia in cancer patientsEuropean Journal Of Cancer, 1993
- Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinomaThe International Journal of Cell Cloning, 1993
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Hodgkin's disease, lymphocyte depletion Type.A clinicopathologic study of 39 patientsCancer, 1978
- Prognostic factors in multiple myelomaCancer, 1975